标题
Targeting Immune Cell Checkpoints during Sepsis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 11, Pages 2413
出版商
MDPI AG
发表日期
2017-11-14
DOI
10.3390/ijms18112413
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Single versus combined immunoregulatory approach using PD-1 and CTLA-4 modulators in controlling sepsis
- (2017) Courtney P. Rudick et al. Expert Review of Clinical Immunology
- Cutting Edge: 2B4-Mediated Coinhibition of CD4+T Cells Underlies Mortality in Experimental Sepsis
- (2017) Ching-wen Chen et al. JOURNAL OF IMMUNOLOGY
- Anti-PD-L1 peptide improves survival in sepsis
- (2017) Yuichiro Shindo et al. JOURNAL OF SURGICAL RESEARCH
- Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality
- (2017) Anna Lange et al. PLoS One
- Flt3 Ligand Treatment Attenuates T Cell Dysfunction and Improves Survival in a Murine Model of Burn Wound Sepsis
- (2017) Naeem K. Patil et al. SHOCK
- Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates
- (2017) Whitney A. Young et al. SURGERY
- Contribution of programmed cell death receptor (PD)-1 to Kupffer cell dysfunction in murine polymicrobial sepsis
- (2016) Fei Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
- (2016) Carolin Fleischmann et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sepsis-induced immune dysfunction: can immune therapies reduce mortality?
- (2016) Matthew J. Delano et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function
- (2016) Yin Guo et al. JOURNAL OF IMMUNOLOGY
- The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes
- (2016) Antonio Hernandez et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1
- (2016) Andriani C. Patera et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- (2016) Celine Boutros et al. Nature Reviews Clinical Oncology
- Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression
- (2016) Naeem K. Patil et al. PHARMACOLOGICAL RESEARCH
- Enhanced Innate Inflammation Induced by Anti-BTLA Antibody in Dual Insult Model of Hemorrhagic Shock/Sepsis
- (2016) Tingting Cheng et al. SHOCK
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of G-CSF in monophosphoryl lipid A-mediated augmentation of neutrophil functions after burn injury
- (2015) Julia K. Bohannon et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Getting sepsis therapy right
- (2015) R. S. Hotchkiss et al. SCIENCE
- Interleukin-7 and Anti–Programmed Cell Death 1 Antibody Have Differing Effects to Reverse Sepsis-Induced Immunosuppression
- (2015) Yuichiro Shindo et al. SHOCK
- Plasma soluble Tim-3 emerges as an inhibitor in sepsis: sepsis contrary to membrane Tim-3 on monocytes
- (2015) F. Ren et al. TISSUE ANTIGENS
- Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression
- (2014) Z. Zhao et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Reactivation of Multiple Viruses in Patients with Sepsis
- (2014) Andrew H. Walton et al. PLoS One
- The Surviving Sepsis Campaign: past, present and future
- (2014) Christa A. Schorr et al. TRENDS IN MOLECULAR MEDICINE
- Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation. Time for a Paradigm Change?
- (2013) Jenneke Leentjens et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response
- (2013) X. Yang et al. JOURNAL OF IMMUNOLOGY
- Identification of B7-H1 as a Novel Mediator of the Innate Immune/Proinflammatory Response as well as a Possible Myeloid Cell Prognostic Biomarker in Sepsis
- (2013) X. Huang et al. JOURNAL OF IMMUNOLOGY
- Kupffer cells potentiate liver sinusoidal endothelial cell injury in sepsis by ligating programmed cell death ligand-1
- (2013) Noelle A. Hutchins et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
- (2013) Richard S Hotchkiss et al. LANCET INFECTIOUS DISEASES
- PD-L1 Blockade Attenuated Sepsis-Induced Liver Injury in a Mouse Cecal Ligation and Puncture Model
- (2013) Weimin Zhu et al. MEDIATORS OF INFLAMMATION
- Epidemiology of severe sepsis
- (2013) Florian B Mayr et al. Virulence
- The changing immune system in sepsis
- (2013) Jonathan S Boomer et al. Virulence
- Virus Detection in Patients with Severe Pneumonia
- (2012) Charles-Edouard Luyt et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction
- (2012) N. J. Shubin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Persistent inflammation and immunosuppression
- (2012) Lori F. Gentile et al. Journal of Trauma and Acute Care Surgery
- Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis
- (2011) Finlay W. McNab et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
- (2011) Jonathan S. Boomer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dose-Dependent Effect of Anti-CTLA-4 on Survival in Sepsis
- (2011) Shigeaki Inoue et al. SHOCK
- Slow Down and Survive: Enigmatic Immunoregulation by BTLA and HVEM
- (2010) Theresa L. Murphy et al. Annual Review of Immunology
- IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis
- (2010) J. Unsinger et al. JOURNAL OF IMMUNOLOGY
- Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis
- (2010) P. Brahmamdam et al. JOURNAL OF LEUKOCYTE BIOLOGY
- ICU-acquired immunosuppression and the risk for secondary fungal infections
- (2010) Guillaume Monneret et al. MEDICAL MYCOLOGY
- Immunotherapy for Sepsis — A New Approach against an Ancient Foe
- (2010) Richard S. Hotchkiss et al. NEW ENGLAND JOURNAL OF MEDICINE
- The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses
- (2009) Alison Crawford et al. CURRENT OPINION IN IMMUNOLOGY
- IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in Sepsis
- (2009) S. Inoue et al. JOURNAL OF IMMUNOLOGY
- Editorial: Therapeutic potential of targeting BTLA
- (2009) Alison Crawford et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The sepsis seesaw: tilting toward immunosuppression
- (2009) Richard S Hotchkiss et al. NATURE MEDICINE
- PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis
- (2009) X. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now